Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Gains from Investment Securities (2020 - 2024)

Alignment Healthcare (ALHC) has disclosed Gains from Investment Securities for 5 consecutive years, with $72000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Gains from Investment Securities rose 120.57% year-over-year to $72000.0, compared with a TTM value of -$269000.0 through Sep 2025, down 176.86%, and an annual FY2024 reading of $9000.0, changed N/A over the prior year.
  • Gains from Investment Securities was $72000.0 for Q2 2025 at Alignment Healthcare, up from -$341000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $350000.0 in Q1 2024 and bottomed at -$350000.0 in Q2 2024.
  • Average Gains from Investment Securities over 4 years is -$343.57, with a median of $17595.0 recorded in 2023.
  • The sharpest move saw Gains from Investment Securities crashed 2089.2% in 2024, then soared 120.57% in 2025.
  • Year by year, Gains from Investment Securities stood at -$101000.0 in 2022, then surged by 117.42% to $17595.0 in 2023, then crashed by 2038.05% to -$341000.0 in 2024, then surged by 121.11% to $72000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for ALHC at $72000.0 in Q2 2025, -$341000.0 in Q4 2024, and $350000.0 in Q3 2024.